By: Beroe Inc. --
20 May, 2014
Supplier Diversity in Pharma: A Strategic Business Opportunity In general, there wasn't much emphasis on supplier diversity at least until a decade ago. However, with rising awareness of Corporate Social Responsibility, companies are consciously making a choice to engage with establishments that are minority-owned, women-owned, LGBT-owned and so on. During the webinar, Beroe's expert Meenakshi L throws light on how procurement of pharmaceutical services from diverse suppliers has evolved in the past few years. The focus is on innovation in procurement as well as on mitigation of challenges arising from engaging with a small diverse supplier. About the speaker: Meenakshi Lakshminarasimhan - Meenakshi is a research biology expert at Beroe Inc. Her category expertise helps her in addressing client specific market and procurement intelligence queries. In her 2 years at Beroe, Meenakshi has built extensive knowledge and expertise in category which includes biology services in drug discovery and development. Meenakshi has written and published several thought leadership papers in leading pharmaceutical industry journals and magazines. One of her articles on Discovery Toxicology Services was published in peer reviewed Pharmaceutical Industry magazine feature of 2013. About the expert: Alis Sindbjerg Hemmingsen - Alis is a procurement thought leader and an expert in helping companies around the world develop and integrate an actionable approach to Responsible Procurement. Alis believes, an actionable approach goes beyond compliance, has a positive effect on the reputation, raises efficiency and generates revenue.
COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)